The graft versus host disease (GvHD) treatment market is projected to grow at a CAGR of 8.50% during the forecast period of 2025–2034. Rising incidence of hematopoietic stem cell transplants, advancements in immunotherapy, and increasing R&D investments are driving the demand for effective GvHD treatment solutions across global healthcare systems. https://www.expertmarketresearch.com/reports/graft-versus-host-disease-treatment-market